Market Overview

Why Shares Of Gilead Sciences Are Trading Higher

Why Shares Of Gilead Sciences Are Trading Higher
Related GILD
Exclusive: Verastem CEO Talks Duvelisib, Pipeline Data, And Further Upside For The Stock
Jim Cramer Advises His Viewers On Seagate, Centurylink And Gilead
Founders Capital Management, Llc Buys Baker Hughes Inc, UnitedHealth Group Inc, Sells Gilead ... (GuruFocus)

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) were trading higher by more than two percent in Friday's pre-market session.

The move is being attributed to a possible report by analysts at RBC stating that the company could launch a buyback program of $10 billion or more.

Gilead Sciences' $138 billion market cap and $7.7 billion in cash and investments (along with $9.4 billion in debt) could support the company tapping into the debt market to undertake such an initiative.

Gilead Sciences previously spent $1.7 billion on buybacks during the third quarter and the company's Chief Financial Officer Robin Washington stated during the post-earnings conference call that buybacks is the preferred method of choice for returning value to shareholders.

Shares were last up 1.7 percent at $92.86 in the pre-market session.

Posted-In: RBC Robin Washington Share BuybacksLong Ideas News Movers Trading Ideas Best of Benzinga


Related Articles (GILD)

View Comments and Join the Discussion!